Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 40 Breast Neoplasms 12 Prostatic Neoplasms 11 Fallopian Tube Neoplasms 10 Pancreatic Neoplasms 7 Neoplasms 7 Endometrial Neoplasms 7 Glioblastoma 6 Neoplasm Metastasis 5 Carcinoma, Ovarian Epithelial 5 Triple Negative Breast Neoplasms 4 Lung Neoplasms 4 Glioma 4 Small Cell Lung Carcinoma 3 Mesothelioma 3 Cystadenocarcinoma, Serous 3 Cholangiocarcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1

Interventions

Fluorodeoxyglucose F18 7 Irinotecan 4 Fluorouracil 4 Cyclophosphamide 4 Bevacizumab 4 toripalimab 3 pembrolizumab 3 olaparib 3 Radiosurgery 3 Cisplatin 3 Capecitabine 3 vistusertib 2 tislelizumab 2 spartalizumab 2 fludarabine 2 atezolizumab 2 apatinib 2 Temozolomide 2 Technetium 2 Specimen Handling 2 Sirolimus 2 Radiotherapy 2 Proton Therapy 2 Paclitaxel 2 Leucovorin 2 Letrozole 2 Hydroxychloroquine 2 Everolimus 2 Drug Therapy 2 Docetaxel 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Solid Tumor × niraparib × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡